Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Loss of TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease accelerator

Blood (2015) 125 (2): 304–315.

https://doi.org/10.1182/blood-2014-04-555508

Published: 2015

Includes: Supplemental data

Journal Articles

Therapies Targeting the MAPK Pathway Improve Bone Marrow (BM) Fibrosis Induced By JAK2V617F

Kotaro Shide, MD PhD, Takuro Kameda, MD, Ayako Kamiunten, MD, Masaaki Sekine, MD, Keiichi Akizuki, MD, Haruko Shimoda, MD PhD, Tomonori Hidaka, MD PhD, Yoko Kubuki, MD, Akira Kitanaka, MD PhD, Kazuya Shimoda, MD PhD

Blood (2014) 124 (21): 162.

https://doi.org/10.1182/blood.V124.21.162.162

Published: 2014

Journal Articles

TET2 Is Essential for Survival in Mice, and Decreased TET2 Expression Enlarges HSC Compartment and Alters Cell Differentiation

Kotaro Shide, MD, PhD, Takuro Kameda, MD, Haruko Shimoda, MD, PhD, Ayako Kamiunten, Masaaki Sekine, Tomonori Hidaka, Keiko Katayose, Yoko Kubuki, Akira Kitanaka, Kazuya Shimoda, MD, PhD

Blood (2011) 118 (21): 2471.

https://doi.org/10.1182/blood.V118.21.2471.2471

Published: 2011

Journal Articles

NS-018, a Potent Novel JAK2 Inhibitor, Effectively Treats Murine MPN Induced by the Janus Kinase 2 (JAK2) V617F Mutant

Kotaro Shide, Yohei Nakaya, Takuro Kameda, Haruko Shimoda, Tomonori Hidaka, Yoko Kubuki, Keiko Katayose, Takuya Matsunaga, Junko Homan, Takashi Kotera, Hiroshi Shibayama, Haruna Naito, Kazuya Shimoda

Blood (2010) 116 (21): 4106.

https://doi.org/10.1182/blood.V116.21.4106.4106

Published: 2010

Journal Articles

Potentiated Activation of VLA-4 and VLA-5 Accelerates Proplatelet-Like Formation In Megakaryocytes.

Takuya Matsunaga, MD, PhD, Fumio Fukai, PhD, Takuro Kameda, MD, Kotaro Shide, MD, PhD, Haruko Shimoda, MD, PhD, Eri Torii, Yasuhiro Taniguchi, Tomonori Hidaka, Keiko Katayose, Yoko Kubuki, Kazuya Shimoda, MD, PhD

Blood (2010) 116 (21): 2585.

https://doi.org/10.1182/blood.V116.21.2585.2585

Published: 2010

Journal Articles

Efficacy of R723, a Potent and Selective JAK2 Inhibitor, in JAK2 V617F-Induced Murine MPD Model.

Kotaro Shide, Takuro Kameda, Vadim Markovtsov, Takuya Matsunaga, Haruko Shimoda, Tomonori Hidaka, Keiko Katayose, Yoko Kubuki, Somasekhar Bhamidipati, Gary Park, Allan Torneros, Matt Duan, Yasumichi Hitoshi, Kazuya Shimoda

Blood (2009) 114 (22): 3897.

https://doi.org/10.1182/blood.V114.22.3897.3897

Published: 2009

Journal Articles

JAK2V617F Mutation Selectively Exerts the STAT3 Pathway for Enhancing a Neutrophil Activation Marker.

Seido Oku, M.D., Katsuto Takenaka, M.D., PhD, Kotaro Shide, M.D., PhD, Takashi Kumano, M.D., Kikushige Yoshikane, M.D., Takuro Kuriyama, M.D., Shingo Urata, M.D., Chika Iwamoto, Takuji Yamauchi, M.D., Haruko Shimoda, MD, PhD, Toshihiro Miyamoto, MD, PhD, Kazuya Shimoda, MD, PhD, Koichi Akashi, MD, PhD

Blood (2009) 114 (22): 1901.

https://doi.org/10.1182/blood.V114.22.1901.1901

Published: 2009

Journal Articles

Absence of Somatically Acquired JAK1 Mutations in Adult T-Cell Leukemia/Lymphoma.

Takuro Kameda, MD, Kotaro Shide, MD, PhD, Haruko Shimoda, MD, PhD, Tomonori Hidaka, MD, PhD, Keiko Katayose, MD, Yasuhiro Taniguchi, MD, Kohich Maeda, MD, Yoko Kubuki, MD, PhD, Takuya Matsunaga, MD, PhD, Kazuya Shimoda, MD, PhD

Blood (2009) 114 (22): 1921.

https://doi.org/10.1182/blood.V114.22.1921.1921

Published: 2009

Journal Articles

Elevated Leukocyte Alkaline Phosphatase Scores Induced by Jak2 V617F Mutation

Seido Oku, MD, Katsuto Takenaka, MD, PhD, Takashi Kumano, MD, Takuro Kuriyama, MD, Shingo Urata, MD, Kotaro Shide, MD, PhD, Haruko Shimoda, MD, PhD, Hiromi Iwasaki, MD, PhD, Toshihiro Miyamoto, MD, PhD, Takanori Teshima, MD, PhD, Koji Nagafuji, MD, PhD, Kazuya Shimoda, MD, PhD, Koichi Akashi, MD, PhD

Blood (2008) 112 (11): 5244.

https://doi.org/10.1182/blood.V112.11.5244.5244

Published: 2008

NARROW

Loss of TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease accelerator

Therapies Targeting the MAPK Pathway Improve Bone Marrow (BM) Fibrosis Induced By JAK2V617F

TET2 Is Essential for Survival in Mice, and Decreased TET2 Expression Enlarges HSC Compartment and Alters Cell Differentiation

NS-018, a Potent Novel JAK2 Inhibitor, Effectively Treats Murine MPN Induced by the Janus Kinase 2 (JAK2) V617F Mutant

Potentiated Activation of VLA-4 and VLA-5 Accelerates Proplatelet-Like Formation In Megakaryocytes.

Efficacy of R723, a Potent and Selective JAK2 Inhibitor, in JAK2 V617F-Induced Murine MPD Model.

JAK2V617F Mutation Selectively Exerts the STAT3 Pathway for Enhancing a Neutrophil Activation Marker.

Absence of Somatically Acquired JAK1 Mutations in Adult T-Cell Leukemia/Lymphoma.

Elevated Leukocyte Alkaline Phosphatase Scores Induced by Jak2 V617F Mutation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only